<table>
<tr>
<th>When T is ...</th>
<th>And N is ...</th>
<th>And M is ...</th>
<th>Then the stage group is ...</th>
</tr>
<tr>
<td>Tis</td>
<td>NO</td>
<td>M0</td>
<td>0</td>
</tr>
<tr>
<td>T1</td>
<td>NO</td>
<td>M0</td>
<td>I</td>
</tr>
<tr>
<td>T2</td>
<td>NO</td>
<td>M0</td>
<td>II</td>
</tr>
<tr>
<td>T3</td>
<td>NO</td>
<td>M0</td>
<td>III</td>
</tr>
<tr>
<td>T1, T2, T3</td>
<td>N1</td>
<td>MO</td>
<td>III</td>
</tr>
<tr>
<td>T4a</td>
<td>NO, N1</td>
<td>M0</td>
<td>IVA</td>
</tr>
<tr>
<td>T1, T2, T3, T4a</td>
<td>N2</td>
<td>MO</td>
<td>IVA</td>
</tr>
<tr>
<td>Any T</td>
<td>N3</td>
<td>MO</td>
<td>IVB</td>
</tr>
<tr>
<td>T4b</td>
<td>Any N</td>
<td>MO</td>
<td>IVB</td>
</tr>
<tr>
<td>Any T</td>
<td>Any N</td>
<td>M1</td>
<td>IVC</td>
</tr>
</table>1\. ENE clinical presence or absence  
2\. ENE pathological presence or absence  
3\. Extent of microscopic ENE (distance of extension
from the native lymph node capsule to the farthest
point of invasion in the extranodal tissue)  
4\. Perineural invasion  
5\. Lymphovascular invasion  
6\. Performance status  
7\. Tobacco use and pack-year  
8\. Alcohol use  
9\. Depression diagnosis<table>
<tr>
<td>G</td>
<td>G Definition</td>
</tr>
<tr>
<td>GX</td>
<td>Grade cannot be assessed</td>
</tr>
<tr>
<td>G1</td>
<td>Well differentiated</td>
</tr>
<tr>
<td>G2</td>
<td>Moderately differentiated</td>
</tr>
<tr>
<td>G3</td>
<td>Poorly differentiated</td>
</tr>
</table>The predominant cancer is squamous cell carcinoma. The
staging guidelines are applicable to all forms of epithelial
carcinoma, including those arising from minor salivary
glands. Other nonepithelial tumors-such as those of lym-
phoid tissue, soft tissue, bone, and cartilage (i.e., lymphoma
and sarcoma)-are not included. Histologic confirmation of
diagnosis is required.  
<!-- PageBreak -->  
<!-- PageNumber="157" -->
<!-- PageHeader="13 Larynx" -->